Get startedLog in
    Picture of Roquefort Therapeutics logo

    ROQ — Roquefort Therapeutics Cashflow Statement

    0.000.00%
    gb flag iconLast trade - 00:00
    FinancialsHighly SpeculativeMicro Cap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Roquefort Therapeutics, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

    2021
    December 31st
    Period Length:12 M
    Source:ARS
    Standards:
    IFRS
    Status:Final
    Net Income/Starting Line-0.996
    Non-Cash Items0.365
    Other Non-Cash Items
    Changes in Working Capital-1.99
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Cash from Operating Activities-2.62
    Other Investing Cash Flow Items-1.11
    Acquisition of Business
    Cash from Investing Activities-1.11
    Financing Cash Flow Items-0.159
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Cash from Financing Activities4.63
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash0.9